Your browser doesn't support javascript.
loading
Role of the prognostic nutritional index in predicting survival in advanced hepatocellular carcinoma treated with regorafenib.
Rimini, Margherita; Yoo, Changoon; Lonardi, Sara; Masi, Gianluca; Piscaglia, Fabio; Kim, Hyung-Don; Rizzato, Mario D; Salani, Francesca; Ielasi, Luca; Forgione, Antonella; Bang, Yeonghak; Soldà, Caterina; Catanese, Silvia; Sansone, Vito; Ryu, Min-Hee; Ryoo, Baek-Yeol; Burgio, Valentina; Cucchetti, Alessandro; Cascinu, Stefano; Casadei-Gardini, Andrea.
Afiliação
  • Rimini M; Division of Oncology, Department of Oncology and Hematology, University Hospital Modena, Modena, Italy.
  • Yoo C; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Lonardi S; Early Phase Clinical Trial Unit, Department of Oncology, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Masi G; Medical Oncology Unit 1, Department of Oncology, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Piscaglia F; Unit of Medical Oncology, Pisa University Hospital, Pisa, Italy.
  • Kim HD; Division of Internal Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Rizzato MD; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Salani F; Medical Oncology Unit 1, Department of Oncology, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Ielasi L; Unit of Medical Oncology, Pisa University Hospital, Pisa, Italy.
  • Forgione A; Division of Internal Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Bang Y; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
  • Soldà C; Division of Internal Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Catanese S; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
  • Sansone V; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Ryu MH; Medical Oncology Unit 1, Department of Oncology, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Ryoo BY; Unit of Medical Oncology, Pisa University Hospital, Pisa, Italy.
  • Burgio V; Division of Internal Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Cucchetti A; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Cascinu S; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Casadei-Gardini A; Department of Oncology, IRCCS San Raffaele Scientific Institute Hospital, Milan, Italy.
Hepatol Res ; 51(7): 796-802, 2021 Jul.
Article em En | MEDLINE | ID: mdl-34005839
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Hepatol Res Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Hepatol Res Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália